1. Home
  2. NRIX vs HLX Comparison

NRIX vs HLX Comparison

Compare NRIX & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRIX
  • HLX
  • Stock Information
  • Founded
  • NRIX 2009
  • HLX 1979
  • Country
  • NRIX United States
  • HLX United States
  • Employees
  • NRIX N/A
  • HLX N/A
  • Industry
  • NRIX Biotechnology: Pharmaceutical Preparations
  • HLX Oilfield Services/Equipment
  • Sector
  • NRIX Health Care
  • HLX Energy
  • Exchange
  • NRIX Nasdaq
  • HLX Nasdaq
  • Market Cap
  • NRIX 970.1M
  • HLX 959.2M
  • IPO Year
  • NRIX 2020
  • HLX 1997
  • Fundamental
  • Price
  • NRIX $11.64
  • HLX $5.97
  • Analyst Decision
  • NRIX Strong Buy
  • HLX Buy
  • Analyst Count
  • NRIX 16
  • HLX 3
  • Target Price
  • NRIX $29.56
  • HLX $12.50
  • AVG Volume (30 Days)
  • NRIX 978.7K
  • HLX 2.0M
  • Earning Date
  • NRIX 07-09-2025
  • HLX 07-23-2025
  • Dividend Yield
  • NRIX N/A
  • HLX N/A
  • EPS Growth
  • NRIX N/A
  • HLX N/A
  • EPS
  • NRIX N/A
  • HLX 0.33
  • Revenue
  • NRIX $88,381,000.00
  • HLX $1,277,904,000.00
  • Revenue This Year
  • NRIX $34.87
  • HLX N/A
  • Revenue Next Year
  • NRIX N/A
  • HLX $7.01
  • P/E Ratio
  • NRIX N/A
  • HLX $18.31
  • Revenue Growth
  • NRIX 41.86
  • HLX N/A
  • 52 Week Low
  • NRIX $8.18
  • HLX $5.52
  • 52 Week High
  • NRIX $29.56
  • HLX $12.89
  • Technical
  • Relative Strength Index (RSI)
  • NRIX 46.20
  • HLX 40.90
  • Support Level
  • NRIX $11.13
  • HLX $6.13
  • Resistance Level
  • NRIX $11.92
  • HLX $6.98
  • Average True Range (ATR)
  • NRIX 0.77
  • HLX 0.31
  • MACD
  • NRIX -0.15
  • HLX -0.00
  • Stochastic Oscillator
  • NRIX 11.79
  • HLX 31.00

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

Share on Social Networks: